TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor

Fatemeh Mohagheghi, Mercedes Prudencio, Cristiana Stuani, Casey Cook, Karen Jansen-West, Dennis W Dickson, Leonard Petrucelli, Emanuele Buratti

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The aggregation and mislocalization of RNA-binding proteins leads to the aberrant regulation of RNA metabolism and is a key feature of many neurodegenerative diseases, including amyotrophic lateral sclerosis and frontotemporal dementia. However, the pathological consequences of abnormal deposition of TDP-43 and other RNA-binding proteins remain unclear, as the specific molecular events that drive neurodegeneration have been difficult to identify and continue to be elusive. Here, we provide novel insight into the complexity of the RNA-binding protein network by demonstrating that the inclusion of exon 17b in the SORT1 mRNA, a pathologically relevant splicing event known to be regulated by TDP-43, is also considerably affected by additional RNA-binding proteins, such as hnRNP L, PTB/nPTB and hnRNP A1/A2. Most importantly, the expression of hnRNP A1/A2 and PTB/nPTB is significantly altered in patients with frontotemporal dementia with TDP-43-positive inclusions (FTLD-TDP), indicating that perturbations in RNA metabolism and processing in FTLD-TDP are not exclusively driven by a loss of TDP-43 function. These results also suggest that a comprehensive assessment of the RNA-binding protein network will dramatically advance our current understanding of the role of TDP-43 in disease pathogenesis, as well as enhance both diagnostic and therapeutic capabilities.

Original languageEnglish (US)
Article numberddv491
Pages (from-to)534-545
Number of pages12
JournalHuman Molecular Genetics
Volume25
Issue number3
DOIs
StatePublished - Feb 1 2016

Fingerprint

Heterogeneous-Nuclear Ribonucleoproteins
RNA-Binding Proteins
Frontotemporal Dementia
Heterogeneous-Nuclear Ribonucleoprotein L
RNA
Neurodegenerative Diseases
Exons
Messenger RNA

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor. / Mohagheghi, Fatemeh; Prudencio, Mercedes; Stuani, Cristiana; Cook, Casey; Jansen-West, Karen; Dickson, Dennis W; Petrucelli, Leonard; Buratti, Emanuele.

In: Human Molecular Genetics, Vol. 25, No. 3, ddv491, 01.02.2016, p. 534-545.

Research output: Contribution to journalArticle

@article{94eec74f49ab4e68aaac125c8f3577a6,
title = "TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor",
abstract = "The aggregation and mislocalization of RNA-binding proteins leads to the aberrant regulation of RNA metabolism and is a key feature of many neurodegenerative diseases, including amyotrophic lateral sclerosis and frontotemporal dementia. However, the pathological consequences of abnormal deposition of TDP-43 and other RNA-binding proteins remain unclear, as the specific molecular events that drive neurodegeneration have been difficult to identify and continue to be elusive. Here, we provide novel insight into the complexity of the RNA-binding protein network by demonstrating that the inclusion of exon 17b in the SORT1 mRNA, a pathologically relevant splicing event known to be regulated by TDP-43, is also considerably affected by additional RNA-binding proteins, such as hnRNP L, PTB/nPTB and hnRNP A1/A2. Most importantly, the expression of hnRNP A1/A2 and PTB/nPTB is significantly altered in patients with frontotemporal dementia with TDP-43-positive inclusions (FTLD-TDP), indicating that perturbations in RNA metabolism and processing in FTLD-TDP are not exclusively driven by a loss of TDP-43 function. These results also suggest that a comprehensive assessment of the RNA-binding protein network will dramatically advance our current understanding of the role of TDP-43 in disease pathogenesis, as well as enhance both diagnostic and therapeutic capabilities.",
author = "Fatemeh Mohagheghi and Mercedes Prudencio and Cristiana Stuani and Casey Cook and Karen Jansen-West and Dickson, {Dennis W} and Leonard Petrucelli and Emanuele Buratti",
year = "2016",
month = "2",
day = "1",
doi = "10.1093/hmg/ddv491",
language = "English (US)",
volume = "25",
pages = "534--545",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor

AU - Mohagheghi, Fatemeh

AU - Prudencio, Mercedes

AU - Stuani, Cristiana

AU - Cook, Casey

AU - Jansen-West, Karen

AU - Dickson, Dennis W

AU - Petrucelli, Leonard

AU - Buratti, Emanuele

PY - 2016/2/1

Y1 - 2016/2/1

N2 - The aggregation and mislocalization of RNA-binding proteins leads to the aberrant regulation of RNA metabolism and is a key feature of many neurodegenerative diseases, including amyotrophic lateral sclerosis and frontotemporal dementia. However, the pathological consequences of abnormal deposition of TDP-43 and other RNA-binding proteins remain unclear, as the specific molecular events that drive neurodegeneration have been difficult to identify and continue to be elusive. Here, we provide novel insight into the complexity of the RNA-binding protein network by demonstrating that the inclusion of exon 17b in the SORT1 mRNA, a pathologically relevant splicing event known to be regulated by TDP-43, is also considerably affected by additional RNA-binding proteins, such as hnRNP L, PTB/nPTB and hnRNP A1/A2. Most importantly, the expression of hnRNP A1/A2 and PTB/nPTB is significantly altered in patients with frontotemporal dementia with TDP-43-positive inclusions (FTLD-TDP), indicating that perturbations in RNA metabolism and processing in FTLD-TDP are not exclusively driven by a loss of TDP-43 function. These results also suggest that a comprehensive assessment of the RNA-binding protein network will dramatically advance our current understanding of the role of TDP-43 in disease pathogenesis, as well as enhance both diagnostic and therapeutic capabilities.

AB - The aggregation and mislocalization of RNA-binding proteins leads to the aberrant regulation of RNA metabolism and is a key feature of many neurodegenerative diseases, including amyotrophic lateral sclerosis and frontotemporal dementia. However, the pathological consequences of abnormal deposition of TDP-43 and other RNA-binding proteins remain unclear, as the specific molecular events that drive neurodegeneration have been difficult to identify and continue to be elusive. Here, we provide novel insight into the complexity of the RNA-binding protein network by demonstrating that the inclusion of exon 17b in the SORT1 mRNA, a pathologically relevant splicing event known to be regulated by TDP-43, is also considerably affected by additional RNA-binding proteins, such as hnRNP L, PTB/nPTB and hnRNP A1/A2. Most importantly, the expression of hnRNP A1/A2 and PTB/nPTB is significantly altered in patients with frontotemporal dementia with TDP-43-positive inclusions (FTLD-TDP), indicating that perturbations in RNA metabolism and processing in FTLD-TDP are not exclusively driven by a loss of TDP-43 function. These results also suggest that a comprehensive assessment of the RNA-binding protein network will dramatically advance our current understanding of the role of TDP-43 in disease pathogenesis, as well as enhance both diagnostic and therapeutic capabilities.

UR - http://www.scopus.com/inward/record.url?scp=84960866390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960866390&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddv491

DO - 10.1093/hmg/ddv491

M3 - Article

VL - 25

SP - 534

EP - 545

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 3

M1 - ddv491

ER -